Search
Now showing items 11-20 of 95
Novel monoamine oxidase inhibitors: a patent review (2012-2014)
(Taylor & Francis, 2015)
Introduction: Monoamine oxidase (MAO) inhibitors, despite the initial pharmacological interest, are used in clinic for their antidepressant effect and in the management of Parkinson symptoms, due to the established ...
The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase
(Elsevier, 2015)
In the present study, series of eight sesamol (1,3-benzodioxol-5-ol) and eight benzodioxane (2,3-dihydro-1,4-benzodioxine) derivatives were synthesised and evaluated as inhibitors of recombinant human monoamine oxidase ...
α-Tetralone derivatives as inhibitors of monoamine oxidase
(Elsevier, 2014)
In the present study, a series of fifteen a-tetralone (3,4-dihydro-2H-naphthalen-1-one) derivatives were
synthesised and evaluated as inhibitors of recombinant human monoamine oxidase (MAO) A and B. The
a-tetralone ...
New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies
(Elsevier, 2014)
Although there are clinical trials and in vivo studies in literature regarding the anxiolytic and antidepressant
activities of the components of Crocus sativus L., their effects on the human monoamine oxidases
(hMAO-A ...
Polycyclic propargylamine and acetylene derivatives as multifunctional neuroprotective agents
(Elsevier, 2014)
The aim of this study was to design drug-like molecules with multiple neuroprotective mechanisms
which would ultimately inhibit N-methyl-D-aspartate (NMDA) receptors, block L-type voltage gated
calcium channels (VGCC) ...
The interactions of azure B, a metabolite of methylene blue, with 2 acetylcholinesterase and butyrylcholinesterase
(Elsevier, 2014)
Methylene blue(MB) is reported to possess diverse pharmacological actions and is attracting increasing attention
for the treatment of neurodegenerative disorders such as Alzheimer's disease. Among the pharmacological
actions ...
Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues
(Wiley, 2014)
Objectives Caffeine represents a useful scaffold for the design of monoamine
oxidase (MAO) type B inhibitors. Specifically, substitution on the C8 position
yields structures which are high-potency MAO-B inhibitors. To ...
Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives
(Elsevier, 2015)
Recent studies have found that phthalonitrile derivatives are remarkably potent inhibitors of human monoamine oxidase (MAO) A and B. In an attempt to further determine the structure-activity relationships (SARs) for MAO ...
An investigation of the monoamine oxidase inhibition properties of pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives
(Wiley, 2018)
In recent studies, we have shown that pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives act as good potency in vitro inhibitors of the monoamine oxidase (MAO) enzymes. To expand on these series and ...
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents
(Elsevier, 2018)
New 4-(3-nitrophenyl)thiazol-2-ylhydrazone derivatives are proposed as dual-target-directed monoamine oxidase B (MAO-B) and acetylcholinesterase (AChE) inhibitors, as well as antioxidant agents, for the treatment of ...